Novavax, Inc. Common Stock (NASDAQ: NVAX) last traded at $8.94, up 6.18% on the session. The quote above updates while this page is open; the figures below are drawn from Novavax, Inc. Common Stock’s own filings and are restated only when a new one is published.
Novavax, Inc. Common Stock trades on NASDAQ under the ticker NVAX. Its market capitalisation is $1.47 billion.
Valuation measures for Novavax, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.47B |
|---|---|
| Enterprise value | $2.43B |
| Price / sales | 3.56 |
| Beta | 1.86 |
Trailing-twelve-month figures tagged in Novavax, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $413.80M |
|---|---|
| Net income (TTM) | -$247.73M |
| EPS (TTM) | -$1.35 |
| Operating margin | -56.58% |
| Cash | $191.46M |
Range and volume for NVAX over the past 52 weeks.
| 52-week high | $11.97 |
|---|---|
| 52-week low | $6.20 |
| Volume | 10.44M |
| Average volume | 4.31M |
| Previous close | $8.42 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.